Cyclophosphamide or chlorambucil therapy is indicated in idiopathic membranous nephropathy with strong risk factors for progression [4] (multiple letters)

American Journal of Kidney Diseases

Volumn 45, Issue 4, 2005, Pages 788-789

  Hebert, Lee A ^a   Rovin, Brad H ^a   Agarwal, Anil K ^a   Spetie, Dan N ^a   Glassock, Richard J ^b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MYCOPHENOLIC ACID; PLACEBO; RITUXIMAB;

ATHEROSCLEROSIS; CREATININE BLOOD LEVEL; DISEASE COURSE; DRUG INDICATION; DRUG TOLERABILITY; HUMAN; IDIOPATHIC DISEASE; KIDNEY BIOPSY; KIDNEY FAILURE; LETTER; MEMBRANOUS GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; REMISSION; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; THROMBOSIS; TREATMENT OUTCOME;

EID: 16244369405     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2005.01.033     Document Type: Letter

References (10)

1. A. Perna A. Schieppati J. Zamora G.A. Giuliano N. Braun G. Remuzzi Immunosuppressive treatment for idiopathic membranous nephropathy A systematic review Am J Kidney Dis 44 2004 385 401
2. S. Troyanov C.A. Wall J.A. Miller J.W. Scholey D.C. Cattran Idiopathic membranous nephropathy Definition and relevance of a partial remission Kidney Int 66 2004 1199 1205
3. R.J. Glassock The treatment of idiopathic membranous nephropathy A dilemma or a conundrum? Am J Kidney Dis 44 2004 562 566
4. L. Hebert Glomerular Diseases The American College of Physicians Nephrology Medical Knowledge Self Assessment Program (MKSAP) 1998 American College of Physicians-American Society of Internal Medicine Philadelphia, PA
5. C. Ponticelli P. Zucchelli P. Passerini A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy Kidney Int 48 1995 1600 1604
6. W.A. Wilmer B.H. Rovin C.J. Hebert S.V. Rao K. Kumor L.A. Hebert Management of glomerular proteinuria A commentary J Am Soc Nephrol 14 2003 3217 3232
7. D.C. Cattran Y. Pei C.M. Greenwood C. Ponticelli P. Passerini E. Honkanen Validation of a predictive model of idiopathic membranous nephropathy Its clinical and research implications Kidney Int 51 1997 901 907
8. D.C. Cattran G.B. Appel L.A. Hebert Cyclosporine in patients with steroid-resistant membranous nephropathy A randomized trial Kidney Int 59 2001 1484 1490
9. D.N. Spetie Y. Tang B.H. Rovin Mycophenolate therapy of SLE membranous nephropathy Kidney Int 66 2004 2411 2415
10. G. Remuzzi C. Chiurchiu M. Abbate V. Brusegan M. Bontempelli P. Ruggenenti Rituximab for idiopathic membranous nephropathy Lancet 360 2002 923 924